Stem-cell–enhanced in‑utero surgery for spina bifida safely protects the fetal spinal cord and has so far prevented shunt ...

Stem-cell–enhanced in‑utero surgery for spina bifida safely protects the fetal spinal cord and has so far prevented shunt ...

Almirall S.A. (ALM), a global biopharmaceutical company dedicated to medical dermatology, is presenting a broad range of ...

By Naa Shormei Odonkor, GNA Kumasi, March 26, GNA – Wing Commander Dr Heindel Tonyi Senayah, a Specialist Obstetrician-Gynaecologist, has called for intensified public education on Pregnancy-Induced ...

Findings show ultraprocessed food consumption before conception influences fertility and embryonic development, urging ...

Many people with an aggressive blood cancer called diffuse large B cell lymphoma are cured by the current gold standard of ...

Support organoid research with scalable human-based systems that enhance reproducibility and accelerate breakthroughs in ...

Positive Phase 3 results of SCOUT-HCM trial highlight potential of Camzyos to be the first cardiac myosin inhibitor for the treatment of adolescents with symptomatic obstructive hypertrophic ...

Positive Data from Phase 2 CADENCE Trial Provides Definitive Proof-of-Concept for Merck’s WINREVAIR in Adults With CpcPH-HFpEF ...

VOYXACT is the first and only FDA-approved treatment for adults with primary IgAN at risk for disease progression that selectively inhibits A PRoliferation Inducing Ligand (APRIL), a key immune driver ...

Total revenues from sales and research collaborations were $0.5 million for fourth quarter and $2.0 million for full year - - Purchase ...

While Similar Symptom Improvement Was Observed Across the Two Arms Relative to Baseline, SENTRY Did Not Meet its Second Co-Primary Endpoint of Abs-TSS - - SENTRY ...